Skip to main content

Table 4 Allele and genotype frequencies of polymorphisms in MTHFR between CAS group and control group

From: Association of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of carotid atherosclerosis: a cross-sectional analysis of 730 Chinese Han adults in Chongqing

 

Allele/Genotype

CAS-group

Control group

OR (CI 95%)

P-value

P for HWE

 

(n = 266)

(n = 464)

   
 

n

%

n

%

   

ALL

C

281

52.8

669

72.1

1

 

0.74

T

251

47.2

259

27.9

2.31(1.85,2.88)

P < 0.001*

 

C/C

58

21.8

249

53.7

1

  

C/T

165

62

171

36.9

4.14 (2.90,5.92)

P < 0.001*

 

T/T

43

16.2

44

9.5

4.20(2.52,6.97)

P < 0.001*

 

Women

C

82

52.6

231

84.9

1

  

T

74

47.4

41

15.1

5.08(3.22,8.03)

P < 0.001*

 

CC

16

20.5

103

75.7

1

  

CT

50

64.1

25

18.4

12.88(6.31,26.26)

P < 0.001*

 

TT

12

15.4

8

5.9

9.66(3.42,27.27)

P < 0.001*

 

Men

C

199

52.9

438

66.8

1

  

T

177

47.1

218

33.2

1.79(1.38,2.32)

P < 0.001*

 

CC

42

22.3

146

44.5

1

  

CT

115

61.2

146

44.5

2.74(1.80,4.17)

P < 0.001*

 

TT

31

16.5

36

11

2.99(1.67,5.40)

P < 0.001*

 
  1. MTHFR Methylenetetrahydrofolate reductase, OR Odds ratio, CI Confidence interval, HWE Hardy-Weinberg equilibrium
  2. *P<0.05 was considered to be statistically significant